Not for the treatment of acute asthma symptoms. Discontinue use if paradoxical bronchospasm occur. Patient w/ severe CV disease; pulmonary TB, or chronic or untreated infections; history of DM. Possible systemic effects including Cushing's syndrome, cushingoid features, adrenal suppression, decrease in bone mineral density, growth retardation in childn & adolescents, cataract & glaucoma. Visual disturbance. Hyperglycaemia. Increased incidence of pneumonia in patients w/ COPD & asthma. Galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Moderate to severe hepatic impairment. Pregnancy & lactation. Childn <12 yr. 200 mcg/25 mcg DPI: Not indicated for COPD.